| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
GigCapital2, Inc. Common Stock$9.94
0 (0%)
Market Cap
-
EPS
-
P/E Ratio
-
Value Trade
12.03 K
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
12.35 K
Monthly Burn
12.35 K
Runway
12,345 mo
Overview
Volume
14.39 K
52 Week Range
-
% held by Insiders
29.71 %
% held by Institutions
57 %
Enterprise Value
-
Total Shares
25.68 M
Short %
0.01 %
Float Shares
25.65 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in GIX
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
GigCapital2, Inc. Common Stock (GIX) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
GIX
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
GIX
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
GIX
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
GIX Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
GIX Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-GIX
Mar 19, 2026GigCapital9 Corp. Announces the Separate Trading of its Class A Ordinary Shares and Rights Commencing
GigCapital9 Corp. has announced that beginning March 19, 2026, holders of its public units can separately trade Class A ordinary shares and rights. Each public unit comprises one Class A ordinary share and one right to an additional Class A share upon a business combination. The Class A shares and rights will trade under the symbols GIX and GIXXR, respectively. The announcement follows an underwritten offering managed by D. Boral Capital LLC, with a final prospectus filed with the SEC.
Read more →-GIX
Jan 28, 2026GigCapital9 Corp. Index to Balance Sheet and Notes to Balance Sheet Report of Independent Registered Public Accounting Firm (PCAOB ID: 207) 2 Balance Sheet 3 Notes to Balance Sheet 4 1 REPORT OF INDEPENDENT REGISTERED PU
GigCapital9 Corp. has successfully completed its initial public offering, raising a total of $253 million. The company's financial statements have been audited and deemed to fairly present its financial position as of January 28, 2026, according to U.S. accounting principles. The offerings include 25,300,000 Units, which will be held in a Trust Account until a designated business combination occurs. The funds raise the potential for future growth once an appropriate merger or acquisition target is identified.
Read more →-GIX
Jan 26, 2026GigCapital9 Corp. Announces Pricing of $220,000,000 Initial Public Offering Palo Alto, CA.
GigCapital9 Corp. has announced the pricing of its $220 million initial public offering of 22 million units, expected to list on NASDAQ under the ticker symbol "GIXXU". Each unit is priced at $10.00 and includes one Class A ordinary share and a right to receive a fraction of a further share. The offering is set to close on January 28, 2026, pending customary closing conditions. D. Boral Capital LLC acts as the sole book-running manager for the offering, which is backed by a registration statement declared effective by the SEC days prior.
Read more →Competitive Position
How GIX ranks across every disease it competes inCompetitive Position is a premium feature
See how GIX ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial